You are here

Relative Bioavailability and Food Effect Study

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
21-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy male or female subjects aged 21 to 55 years

- Healthy is defined as no clinical relevant abnormalities identified by a detailed
medical history, full physical examination including blood pressure and pulse rate
measurement, 12-lead ECG and clinical laboratory tests

- Willing to use acceptable methods of contraception as outlined in the study protocol

- Body mass index between 18 to 30 kg/m2

- Subjects who are willing and able to comply with the scheduled visits, treatment plan
and other study procedures

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with evidence or history of clinically significant disease

- Pregnant or nursing females

- Females of childbearing potential who are unwilling or unable to use an acceptable
method of nonhormonal contraception from at least 14 days prior to the first dose
until day 15 of period 4

- Subjects with conditions possibly affecting drug absorption (eg gastrectomy)

- A positive approved immunoassay/ELISA blood test for TB

- Subjects with a history of regular alcohol consumption exceeding 14 drinks/week for
females or 21 drinks/week for men

- Subjects who have use prescription or nonprescription drugs, vitamins and/or dietary
supplements within 7 days or 5 half-lives (whichever is longer) prior to the first
dose of study medication

- Subjects who have been administered medications capable of inducing hepatic enzyme
metabolism (eg barbiturates, rifampin, carbamazepine, phenytoin or primidone) within
14 days (or 5 half-lives of the inducing agent, whichever is longer) of day 1 or
within 28 days of administration of St John's wort

NCT00827515
Pfizer
Withdrawn
Relative Bioavailability and Food Effect Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Pain
NCT02863575
All Genders
16+
Years
Salt Lake City, Utah
Chronic Pain, Hip Osteoarthritis, Knee Osteoarthritis
NCT02528188
All Genders
18+
Years
Multiple Sites
Moderate-severe Pain
NCT02101554
All Genders
7+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now